Sentynl Therapeutics, Inc.

Major Drugs - , ,

Sentynl Therapeutics, Inc. Details

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Cadila Pharmaceuticals, is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Sentynl Therapeutics, Inc. logo, Sentynl Therapeutics, Inc. contact details
Website: sentynl.com
Employees: 20 - 49
HQ: 888-227-8725
Location: , ,
Revenue: 5 - 10 Million
N/A
Sentynl Therapeutics, Inc. Technologies
Email Providers

Outlook

Load Balancers

Apache

CMS

WordPress.org

Fonts

Google Font API

Tag Management

Google Tag Manager

Analytics and Tracking

Google Analytics

View All Technologies Used At Sentynl Therapeutics, Inc.

Contacting Sentynl Therapeutics, Inc.: Connect with Executives and Employees

Get in Touch with Sentynl Therapeutics, Inc. Executives and Employees

Connecting with Sentynl Therapeutics, Inc.'s Executives and Workforce

Accessing Contact Information for Sentynl Therapeutics, Inc. Executives

Connecting with Sentynl Therapeutics, Inc.: Reach Out to Their Team

Discover How to Contact Sentynl Therapeutics, Inc. Executives and Staff

Looking to connect with Sentynl Therapeutics, Inc. executives or employees?

Seeking to Get in Touch with Sentynl Therapeutics, Inc. Executives or Staff?

Want to Reach Out to Sentynl Therapeutics, Inc. Executives or Team Members?

In Search of Contact Details for Sentynl Therapeutics, Inc. Professionals?

Connecting with Sentynl Therapeutics, Inc.: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z